ImmunoGen Inc
XETRA:IMU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
|
A
|
AnGes Inc
OTC:AMGXF
|
JP |
|
U
|
Unifiedpost Group SA
XBRU:UPG
|
BE |
|
Brouwerij - Handelsmaatschappij NV
XBRU:COBH
|
BE |
|
H
|
Hiroca Holdings Ltd
TWSE:1338
|
CN |
|
K
|
Keynote Financial Services Ltd
NSE:KEYFINSERV
|
IN |
|
Metalurgica Gerdau SA
BOVESPA:GOAU4
|
BR |
|
Lion Metal Works Tbk PT
IDX:LION
|
ID |
|
Dole PLC
NYSE:DOLE
|
IE |
|
Lakeland Industries Inc
NASDAQ:LAKE
|
US |
|
C
|
Cibus Inc
NASDAQ:CBUS
|
US |
|
Coca-Cola Consolidated Inc
NASDAQ:COKE
|
US |
|
Eole Inc
TSE:2334
|
JP |
|
A
|
Asset World Corp PCL
SET:AWC
|
TH |
|
Southwest Gas Holdings Inc
NYSE:SWX
|
US |
|
SIG Group AG
OTC:SCBGF
|
CH |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
CN |
|
Suzuki Co Ltd
TSE:6785
|
JP |
|
M
|
Metalurgica Gerdau SA
BOVESPA:GOAU3
|
BR |
|
T
|
Toyo Shutter Co Ltd
TSE:5936
|
JP |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
Megaport Ltd
ASX:MP1
|
AU |
Bankruptcy Probability
ImmunoGen Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ImmunoGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
ImmunoGen Inc
XETRA:IMU
|
1.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
361.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ImmunoGen Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ImmunoGen Inc has total debt of 88.6m USD. This includes both short-term (0 USD) and long-term (88.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
